HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) IN ENGLAND: A RETROSPECTIVE OBSERVATIONAL COHORT STUDY

被引：0
|
作者：
Siddiqui, S. [1 ]
Dolin, P. [2 ]
Shavit, A. [2 ]
Rowell, J. [3 ]
Edmonds, C. [4 ]
Kielar, D. [2 ]
Persson, J. [5 ]
Lacetera, A. [6 ]
Suarez-Sanchez, P. [6 ]
Ariti, C. [6 ]
Podmore, B. [6 ]
Velarde, A. Kitchin [6 ]
Chen, S. Y. [7 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, NIHR Imperial Biomed Res Ctr, London, England
[2] AstraZeneca, BioPharmaceut Med, Cambridge, England
[3] AstraZeneca, Market Access & Pricing, Cambridge, England
[4] AstraZeneca, Market Access & Pricing, Gaithersburg, MD USA
[5] AstraZeneca, Market Access & Pricing, Gothenburg, Sweden
[6] OXONEpidemiology, Madrid, Spain
[7] AstraZeneca, BioPharmaceut Med, Gaithersburg, MD USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE428
引用
收藏
页码：S139 / S140
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of IFN-Alpha in Induction and Maintenance of Remission in Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA). Single Center Observational Study
    Seeliger, Benjamin
    Foerster, Martin
    Moeser, Anne
    Happe, Janett
    Kroegel, Claus
    Neumann, Thomas
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S787 - S787
  • [22] Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study
    Mattioli, Irene
    Urban, Maria Letizia
    Padoan, Roberto
    Mohammad, Aladdin J.
    Salvarani, Carlo
    Baldini, Chiara
    Berti, Alvise
    Cameli, Paolo
    Caminati, Marco
    Cathebras, Pascal
    Bianchi, Fulvia Chieco
    Cinetto, Francesco
    Tervaert, Jan Willem Cohen
    Coppola, Angelo
    Costanzo, Giulia
    Cottin, Vincent
    Crimi, Claudia
    Del Giacco, Stefano
    Desaintjean, Charlene
    Egan, Allyson
    Espigol-Frigole, Georgina
    Folci, Marco
    Fornaro, Marco
    Franceschini, Franco
    Govoni, Marcello
    Groh, Matthieu
    Guarnieri, Gabriella
    Hellmich, Bernhard
    Iannone, Florenzo
    Jones, Rachel
    Kernder, Anna
    Lo Gullo, Alberto
    Lombardi, Carlo
    Lopalco, Giuseppe
    Losappio, Laura
    Marchi, Maria Rita
    Rivera, Carlos Martinez
    Marvisi, Chiara
    Maule, Matteo
    Moi, Laura
    Monti, Sara
    Moosig, Frank
    Moroncini, Gianluca
    Negrini, Simone Matteo
    Neumann, Thomas
    Nolasco, Santi
    Novikov, Pavel
    Roccatello, Dario
    Samson, Maxime
    Schroeder, Jan Walter
    JOURNAL OF AUTOIMMUNITY, 2025, 153
  • [23] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
    Tencer, T.
    Xia, Q.
    Jobson, G.
    Qian, E.
    Dellon, E. S.
    VALUE IN HEALTH, 2022, 25 (07) : S432 - S432
  • [24] Interferon-α for Induction and Maintenance of Remission in Eosinophilic Granulomatosis with Polyangiitis: A Single-center Retrospective Observational Cohort Study
    Seeliger, Benjamin
    Foerster, Martin
    Happe, Janett
    Forberg, Thomas
    Moeser, Anne
    Neumann, Thomas
    Kroegel, Claus
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 806 - 814
  • [25] Incremental Healthcare Resource Utilization and Costs of Herpes Zoster in Patients with Psoriatic Arthritis: A Retrospective Cohort Study
    Singer, David
    Thompson-Leduc, Philippe
    Ma, Siyu
    Gupta, Deepshekhar
    Cheng, Wendy
    Sendhil, Selvam
    Sundar, Manasvi
    Hagopian, Ella
    Duh, Mei Sheng
    Poston, Sara
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2939 - 2941
  • [26] Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study
    Hudesman, David P.
    Chakravarty, Soumya D.
    Emond, Bruno
    Ellis, Lorie A.
    Lefebvre, Patrick
    Sadik, Kay
    Scher, Jose U.
    BMC RHEUMATOLOGY, 2020, 4 (01)
  • [27] Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study
    David P. Hudesman
    Soumya D. Chakravarty
    Bruno Emond
    Lorie A. Ellis
    Patrick Lefebvre
    Kay Sadik
    Jose U. Scher
    BMC Rheumatology, 4
  • [28] Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort study
    Shiomi, Mayu
    Watanabe, Ryu
    Matsuda, Shogo
    Kotani, Takuya
    Okazaki, Ayana
    Masuda, Yuichi
    Yoshida, Tsuneyasu
    Shoji, Mikihito
    Tsuge, Ryosuke
    Kadoba, Keiichiro
    Hiwa, Ryosuke
    Yamamoto, Wataru
    Takeda, Akitoshi
    Itoh, Yoshiaki
    Hashimoto, Motomu
    MODERN RHEUMATOLOGY, 2024,
  • [29] Clinical features of central nervous system involvement in patients with eosinophilic granulomatosis with polyangiitis: a retrospective cohort study in China
    Suying Liu
    Ling Guo
    Xiaoyuan Fan
    Zhaocui Zhang
    Jiaxin Zhou
    Xinping Tian
    Mengtao Li
    Xiaofeng Zeng
    Li Wang
    Fengchun Zhang
    Orphanet Journal of Rare Diseases, 16
  • [30] Clinical features of central nervous system involvement in patients with eosinophilic granulomatosis with polyangiitis: a retrospective cohort study in China
    Liu, Suying
    Guo, Ling
    Fan, Xiaoyuan
    Zhang, Zhaocui
    Zhou, Jiaxin
    Tian, Xinping
    Li, Mengtao
    Zeng, Xiaofeng
    Wang, Li
    Zhang, Fengchun
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
12345